Conversely, findings from a cohort study encompassing 784 cases of prostate cancer and a corresponding control group indicated that the median plasma selenium levels and SelP concentrations were similar between the two groups, with a notable elevation in high-grade prostate cancer cases (106). This evidence concerns the gene SELP and Familial prostate cancer.